I agree completely but overall I think the hepatotoxicity from oral steroids have been exaggerated as simply using AST/ALT ratios (which is what most use to gauge) can be misleading
http://anabolicminds.com/forum/steroids/199435-anabolic-steroid-induced.html
There is no doubt that androgens have a significant effect on our lipids however these androgen induced declines in HDL does not automatically have to be assumed to be proatherogenic but instead may be the result of accelerated reverse cholesterol transport and not necessarily equal an increased CVD risk.
Androgens increase the activity of hepatic triglyceride lipase (HTGL) (PMID:4033402) and it is believed that HTGL activity is pretty protective against CVD risk (PMID:7853704) which then ask the question, does the reduced amount of HDL particles one experiences as a result from androgen use actually lead to an increased CVD risk considering the protective activity of some of the HDL fractions are not reduced?